Keratoconus appears both more common and more severe in Aotearoa than in many other countries and it has been the most common indication for corneal transplantation in New Zealand for several decades. Collagen corneal cross-linking (CXL) provides the opportunity to halt or slow the progression of keratoconus and has been available in Auckland since 2007.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
